-
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer's disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the [...]
-
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer's disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the [...]
-
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer's disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the [...]
-
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer’s disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the [...]
-
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer’s disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the [...]
-
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer’s disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the [...]
-
A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer’s disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the [...]
-
An article published in the Journal of Fungi analyzing bloodstream infection by fungi of the genus Candida, and comparing data for the periods 2010-11 and 2017-18 in Brazil, shows the persistence of extremely high mortality rates despite advances in therapeutic practices. Candidemia is the world's most prevalent nosocomial (hospital-acquired) invasive fungal infection. Its incidence varies globally from 0.33 to 6.51 episodes per 1,000 admissions.
The study was supported [...]
-
Foram anunciados ontem (29) os cinco novos Centros de Pesquisa, Inovação e Difusão (CEPIDs) que serão apoiados pela FAPESP por um período inicial de cinco anos, que poderá ser estendido, no máximo, por mais dois períodos de três anos. Os projetos foram selecionados entre as 38 propostas submetidas ao edital lançado em 2021, abrangendo as ciências de saúde, biológicas, agronomia e veterinária.
A [...]
-
Foram anunciados ontem (29) os cinco novos Centros de Pesquisa, Inovação e Difusão (CEPIDs) que serão apoiados pela FAPESP por um período inicial de cinco anos, que poderá ser estendido, no máximo, por mais dois períodos de três anos. Os projetos foram selecionados entre as 38 propostas submetidas ao edital lançado em 2021, abrangendo as ciências de saúde, biológicas, agronomia e veterinária.
A [...]
